A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

Clinical trial NCT07683065 · RECRUITING

Trial details

NCT number: NCT07683065
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Plaque Psoriasis Metabolic Dysfunction-Associated Steatotic Liver Disease

Start date: 2026-07-08
Primary completion: 2027-01-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.